使用基于网络的认知电池检测阿尔茨海默病的早期阶段
Jordan R Hoffmeister1, Brady R Robison2, Christopher T Copeland2
1Department of Psychiatry and Behavioral Sciences, The University of Oklahoma Health Science Center, Oklahoma City, OK, USA. jordanhoffmeister@gmail.com.
GeroScience
|December 31, 2024
概括
神经轨道认知电池 (NCB) 在早期发现阿尔茨海默病方面表现有前途. 这种基于网络的工具准确地识别轻度认知障碍,有助于早期诊断和研究.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 老年学是一门学科.
背景情况:
- 由于阿尔茨海默病的流行率不断增加,早期发现阿尔茨海默病 (AD) 是至关重要的.
- 需要便携式和高效的认知查工具来实现广泛的可访问性.
- 神经轨道认知电池 (NCB) 是一个基于网络的应用程序,旨在进行认知评估.
研究的目的:
- 调查NCB的构造和诊断有效性.
- 评估国家央行在区分有或没有轻度认知障碍 (MCI) 的个人方面的有效性.
- 评估NCB作为早期阿尔茨海默病查工具的潜力.
主要方法:
- 招募了47名MCI和没有MCI的参与者.
- 参与者完成了NCB和传统的认知测试.
- 统计分析评估了NCB指标与已确定的认知测试之间的关联,以及MCI的分类准确性.
主要成果:
- 三个NCB指标 (内存,处理速度,执行功能) 与传统测试有中度至强度的相关性.
- 对于MCI分类,NCB衡量灵敏度在0.47至0.74之间,具体度在0.78至1.00.之间.
- 传统的认知指标具有从0.74到0.84的灵敏度和从0.74到0.94.9的特异性.
结论:
- 基于网络的认知测试评估记忆,处理速度和执行功能可以作为早期阿尔茨海默病检测的便携式查工具.
- 国家央行证明了识别与MCI相关的认知变化的潜在有效性.
- 研究结果支持这些认知领域在阿尔茨海默病逆向翻译研究中的实用性.
相关概念视频
Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444


